| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 12,000,000 | 76,440,000 | 25.99% | ||
| 2 | Idenix Pharmaceuticals Inc | 2,000,000 | 48,200,000 | 16.39% | ||
| 3 | QUEST DIAGNOSTICS INC | 775,000 | 45,485,000 | 15.47% | ||
| 4 | BIO-REFERENCE LABS INC | 1,280,984 | 38,711,000 | 13.16% | ||
| 5 | MERCK & CO INC | 400,000 | 23,140,000 | 7.87% | ||
| 6 | REPROS THERAPEUTICS INC | 1,003,367 | 17,358,000 | 5.90% | ||
| 7 | VIVUS INC | 2,573,943 | 13,693,000 | 4.66% | ||
| 8 | AMGEN INC | 45,000 | 5,327,000 | 1.81% | ||
| 9 | AVEO PHARMACEUTICALS INC | 2,570,759 | 4,704,000 | 1.60% | ||
| 10 | ENANTA PHARMACEUTICALS INC COM | 105,000 | 4,522,000 | 1.54% | ||
| 11 | KINDRED BIOSCIENCES INC | 228,126 | 4,252,000 | 1.45% | ||
| 12 | LABORATORY CORP AMER HLDGS | 37,824 | 3,873,000 | 1.32% | ||
| 13 | INTRA CELLULAR THERAPIES INC COM | 215,202 | 3,628,000 | 1.23% | ||
| 14 | TARGACEPT INC | 630,000 | 2,841,000 | 0.97% | ||
| 15 | ONCONOVA THERAPEUTICS | 350,000 | 1,901,000 | 0.65% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-14-032743, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
